Indistinguishable disease states in diffuse large B-cell lymphoma unraveled by microarray expression profiles: A new basis for therapy selection. (pages 68–74)
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program
Breast Cancer Research Open Access 23 January 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Shipp, M.A. et al. Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nature Med. 8, 68–74 (2002).
Shipp, M.A. et al. A predictive model for aggressive non-Hodgkin's Lymphoma. New Engl. J. Med. 329, 987–994 (1993).
Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).
Quackenbush, J. Computational analysis of microarray data. Nature Rev. Genet. 2, 418–427 (2001).
Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536–540 (2000).
Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).
Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869–10874 (2001).
Scherf, U. et al. A gene expression database for the molecular pharmacology of cancer. Nature Genet. 24, 236–244 (2000).
Fisher R.I. et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New Engl. J. Med. 328, 1002–1006 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van't Veer, L., De Jong, D. The microarray way to tailored cancer treatment. Nat Med 8, 13–14 (2002). https://doi.org/10.1038/nm0102-13
Issue Date:
DOI: https://doi.org/10.1038/nm0102-13
This article is cited by
-
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program
Breast Cancer Research (2017)
-
Technology Insight: tuning into the genetic orchestra using microarrays—limitations of DNA microarrays in clinical practice
Nature Clinical Practice Oncology (2006)
-
42nd Annual Meeting of the American Society for Cell Biology, San Francisco, California, USA, 14–18 December 2002
Breast Cancer Research (2003)
-
Clinical biomarkers in drug discovery and development
Nature Reviews Drug Discovery (2003)